These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29629405)

  • 1. Evaluation of Systemic Corticosteroids in Patients With an Acute Exacerbation of COPD and a Diagnosis of Pneumonia.
    Scholl T; Kiser TH; Vondracek SF
    Chronic Obstr Pulm Dis; 2018 Jan; 5(1):57-65. PubMed ID: 29629405
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of corticosteroids on the duration of ventilatory support during severe acute exacerbations of chronic obstructive pulmonary disease in patients in the intensive care unit: a study protocol for a multicentre, randomized, placebo-controlled, double-blind trial.
    Ferré A; Thille AW; Mekontso-Dessap A; Similowski T; Legriel S; Aegerter P; Demoule A;
    Trials; 2023 Mar; 24(1):231. PubMed ID: 36967375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Community-acquired Pneumonia on Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients as Regards In-hospital Complications and Early Readmission.
    Ruby D
    Open Respir Med J; 2020; 14():10-15. PubMed ID: 32509036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Woods JA; Wheeler JS; Finch CK; Pinner NA
    Int J Chron Obstruct Pulmon Dis; 2014; 9():421-30. PubMed ID: 24833897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Steroid and Nebulized Budesonide Combination Therapy Versus Systemic Steroid Monotherapy in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in a Community Hospital: A Retrospective Cohort Study.
    Nguyen D; Larson T; Leinbach H; Guthrie E
    Hosp Pharm; 2021 Dec; 56(6):786-791. PubMed ID: 34732939
    [No Abstract]   [Full Text] [Related]  

  • 6. 30-day Readmission After an Acute Exacerbation of Chronic Obstructive Pulmonary Disease is Associated with Cardiovascular Comorbidity.
    Ozgen Alpaydin A; Ozuygur SS; Sahan C; Tertemiz KC; Russell R
    Turk Thorac J; 2021 Sep; 22(5):369-375. PubMed ID: 35110209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients.
    Dixit D; Bridgeman MB; Andrews LB; Narayanan N; Radbel J; Parikh A; Sunderram J
    Pharmacotherapy; 2015 Jun; 35(6):631-48. PubMed ID: 26032691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids for severe acute exacerbations of chronic obstructive pulmonary disease in intensive care: From the French OUTCOMEREA cohort.
    Galerneau LM; Bailly S; Terzi N; Ruckly S; Garrouste-Orgeas M; Cohen Y; Hong Tuan Ha V; Gainnier M; Siami S; Dupuis C; Darmon M; Azoulay E; Forel JM; Sigaud F; Adrie C; Goldgran-Toledano D; Ferré A; de Montmollin E; Argaud L; Reignier J; Pepin JL; Timsit JF;
    PLoS One; 2023; 18(4):e0284591. PubMed ID: 37075003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease.
    Osadnik CR; Tee VS; Carson-Chahhoud KV; Picot J; Wedzicha JA; Smith BJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004104. PubMed ID: 28702957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early readmission and mortality in acute exacerbation of chronic obstructive pulmonary disease with community-acquired pneumonia.
    Shin B; Kim SH; Yong SJ; Lee WY; Park S; Lee SJ; Lee SJ; Lee MK
    Chron Respir Dis; 2019; 16():1479972318809480. PubMed ID: 30428701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study.
    Johannesdottir SA; Christiansen CF; Johansen MB; Olsen M; Xu X; Parker JM; Molfino NA; Lash TL; Fryzek JP
    J Med Econ; 2013 Jul; 16(7):897-906. PubMed ID: 23621504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: a cohort study.
    Gulati S; Zouk AN; Kalehoff JP; Wren CS; Davison PN; Kirkpatrick DP; Bhatt SP; Dransfield MT; Wells JM
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2271-2278. PubMed ID: 30100717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and outcomes of diabetic patients with acute exacerbation of COPD.
    Monsour E; Rodriguez LM; Abdelmasih R; Tuna K; Abusaada K
    J Diabetes Metab Disord; 2021 Jun; 20(1):461-466. PubMed ID: 34178851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Eosinophils and Clinical Outcomes in Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study.
    Pu J; Yi Q; Luo Y; Wei H; Ge H; Liu H; Li X; Zhang J; Pan P; Zhou H; Zhou C; Yi M; Cheng L; Liu L; Zhang J; Peng L; Aili A; Liu Y; Zhou H;
    Int J Chron Obstruct Pulmon Dis; 2023; 18():169-179. PubMed ID: 36879668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical investigation on the related factors for the application of systemic glucocorticoids in patients with acute exacerbation of chronic obstructive pulmonary disease with carbon dioxide retention].
    Jiao W; Zhang W; Zhang C; Liu Z; Gan Y; Peng Z; Yan G; Deng X; Xue Q; Wu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1061-1066. PubMed ID: 33081891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Clinical Outcomes Between Nebulized and Systemic Corticosteroids in the Treatment of Acute Exacerbation of COPD in China (CONTAIN Study): A Post Hoc Analysis.
    Chen Y; Liu Y; Zhang J; Yao W; Yang J; Li F; Lu L; Zheng J; Han X; Xu JF
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2343-2353. PubMed ID: 33061352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective evaluation of systemic corticosteroids for the management of acute exacerbations of chronic obstructive pulmonary disease.
    Vondracek SF; Hemstreet BA
    Am J Health Syst Pharm; 2006 Apr; 63(7):645-52. PubMed ID: 16554288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol.
    Sivapalan P; Moberg M; Eklöf J; Janner J; Vestbo J; Laub RR; Browatzki A; Armbruster K; Wilcke JT; Seersholm N; Weinreich UM; Titlestad IL; Andreassen HF; Ulrik CS; Bødtger U; Nielsen TL; Hansen EF; Jensen JUS
    BMC Pulm Med; 2017 Aug; 17(1):114. PubMed ID: 28810909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials.
    Sivapalan P; Rutishauser J; Ulrik CS; Leuppi JD; Pedersen L; Mueller B; Eklöf J; Biering-Sørensen T; Gottlieb V; Armbruster K; Janner J; Moberg M; Lapperre TS; Nielsen TL; Browatzki A; Mathioudakis A; Vestbo J; Schüetz P; Jensen JU
    Respir Res; 2021 May; 22(1):155. PubMed ID: 34020641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and profile of severe exacerbations of chronic obstructive pulmonary disease due to biomass smoke or tobacco.
    Golpe R; Blanco-Cid N; Dacal-Rivas D; Martín-Robles I; Veiga I; Guzmán-Peralta I; Castro-Añón O; Pérez-de-Llano LA
    Ann Thorac Med; 2022; 17(4):193-198. PubMed ID: 36387759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.